Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus (Q34982099)

5 August 2017

1 reference

title

Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus (English)

1 reference

5 August 2017

2

Greg L Plosker

1 reference

5 August 2017

Christopher J Dunn

1

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

20

1 reference

5 August 2017

issue

14

1 reference

5 August 2017

page(s)

989-1025

1 reference

Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps

5 August 2017

cites work

1 reference

12 December 2020

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

1 reference

12 December 2020

Medical care expenditures for diabetes, its chronic complications, and its comorbidities.

1 reference

12 December 2020

Insulin lispro in CSII: results of a double-blind crossover study

1 reference

12 December 2020

Lispro insulin in type 1 diabetic patients on a Mediterranean or normal diet: a randomized, cross-over comparative study with regular insulin.

1 reference

12 December 2020

Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus

1 reference

12 December 2020

Prevalence of diabetes and effect on quality of life in older French living in the community: the PAQUID Epidemiological Survey

1 reference

12 December 2020

Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin

1 reference

12 December 2020

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group

1 reference

12 December 2020

Diabetes: the cost of illness in Sweden

1 reference

12 December 2020

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents

1 reference

12 December 2020

The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes

1 reference

12 December 2020

Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach.

1 reference

12 December 2020

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

1 reference

12 December 2020

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide

1 reference

12 December 2020

Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

1 reference

12 December 2020

NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care

1 reference

12 December 2020

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

1 reference

12 December 2020

Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group

1 reference

12 December 2020

The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approach

1 reference

12 December 2020

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabet

1 reference

12 December 2020

Quality of life and diabetes

1 reference

12 December 2020

Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group

1 reference

12 December 2020

Insulin lispro lowers postprandial glucose in prepubertal children with diabetes

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Conversion of fast insulin intensive therapy to lispro insulin in type I diabetes. Pharmacoeconomic analysis of cost-effectiveness

1 reference

12 December 2020

Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus

1 reference

12 December 2020

Economic evaluation of drug therapy: a review of the contingent valuation method

1 reference

12 December 2020

Insulin lispro and regular insulin in pregnancy

1 reference

12 December 2020

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

1 reference

12 December 2020

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

1 reference

12 December 2020

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

12 December 2020

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

12 December 2020

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes

1 reference

12 December 2020

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime

1 reference

12 December 2020

The economics of pharmacotherapy for diabetes mellitus

1 reference

12 December 2020

Costs of diabetes. A methodological analysis of the literature.

1 reference

12 December 2020

Economic evaluation in health care: is there a role for cost-benefit analysis?

1 reference

12 December 2020

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes

1 reference

12 December 2020

Prescription drug use and costs among diabetic patients in primary health care practices in Germany

1 reference

12 December 2020

Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus

1 reference

12 December 2020

Coping with Type II diabetes: the patient's perspective.

1 reference

12 December 2020

Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.

1 reference

12 December 2020

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

1 reference

12 December 2020

Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996.

1 reference

12 December 2020

The outpatient cost of diabetes care in Italian diabetes centers

1 reference

12 December 2020

A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents

1 reference

12 December 2020

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

1 reference

12 December 2020

Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial

1 reference

12 December 2020

Willingness to pay and the valuation of programmes for the prevention and control of influenza.

1 reference

12 December 2020

Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis.

1 reference

12 December 2020

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group

1 reference

12 December 2020

Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus

1 reference

12 December 2020

Relationship of health-related quality of life to symptom severity in diabetes mellitus: a study in Trinidad and Tobago.

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Social inequalities in morbidity from diabetes mellitus in public primary care clinics in Trinidad and Tobago.

1 reference

12 December 2020

Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection.

1 reference

12 December 2020

A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump

1 reference

12 December 2020

Safety of insulin lispro: pooled data from clinical trials.

1 reference

12 December 2020

Effect of improved glycemic control on health care costs and utilization

1 reference

12 December 2020

Revealing the cost of Type II diabetes in Europe.

1 reference

12 December 2020

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

1 reference

12 December 2020

A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.

1 reference

12 December 2020

Quality of life associated with diabetes mellitus in an adult population.

1 reference

12 December 2020

Italian multicentre study of intensive therapy with insulin lispro in 1184 patients with Type 1 diabetes

1 reference

12 December 2020

Treatment of type 1 diabetes with insulin lispro during Ramadan.

1 reference

12 December 2020

Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care.

1 reference

12 December 2020

Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes

1 reference

12 December 2020

Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus

1 reference

12 December 2020

Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire.

1 reference

12 December 2020

The Economic Cost of Diabetes in Canada, 1998

1 reference

12 December 2020

The cost to health plans of poor glycemic control

1 reference

12 December 2020

Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study

1 reference

12 December 2020

Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: assessment of improvements in treatment satisfaction with a new insulin analogue.

1 reference

12 December 2020

Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes

1 reference

12 December 2020

1 reference

12 December 2020

Psychometric properties of the Questionnaire on Stress in Patients with Diabetes--Revised (QSD-R)

1 reference

12 December 2020

Quality of life and associated characteristics in a large national sample of adults with diabetes.

1 reference

12 December 2020

Model of complications of NIDDM. I. Model construction and assumptions.

1 reference

12 December 2020

Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group

1 reference

12 December 2020

Resource utilization and costs of care in the diabetes control and complications trial

1 reference

12 December 2020

Direct health care costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO

1 reference

12 December 2020

10.2165/00019053-200220140-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1007344543

0 references

1 reference